The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

被引:0
|
作者
Tefera, S [1 ]
Hatlebakk, JG [1 ]
Berstad, A [1 ]
机构
[1] Univ Bergen, Haukeland Hosp, Dept Med A, Div Gastroenterol, N-5021 Bergen, Norway
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Increased prevalence of oesophagitis has been reported following eradication of Helicobacter pylori. We hypothesized that H. pylori eradication might increase gastro-oesophageal acid reflux in patients with reflux oesophagitis. Methods: Twenty-five consecutive patients (13 male, 12 female) with H, pylori infection and reflux oesophagitis grade I (22 patients) or II (three patients) were enrolled; mean age 49.9 (range 33-75) years. Twenty-four hour intra-oesophageal pH recording was performed before and 12 weeks after eradication of H, pylori, which was achieved using bismuth subnitrate suspension 150 mg q.d.s., oxytetracycline 500 mg q.d.s, and metronidazole 400 mg t.d.s, for 10 days, Eradication was confirmed by C-14-urea breath test 12 weeks after completion of treatment. The patients did not receive acid-suppressive medication. Results: All patients had abnormal gastro-oesophageal reflux before anti-H. pylori treatment. After treatment, there was no significant change in the percentage of total time oesophageal pH < 4 (P = 0.46) in the 23 patients in whom the infection had been cured. Nine of the cured patients had increased acid exposure, whereas 14 had decreased acid exposure. No significant change in reflux symptom scores was found. There was no relationship between change in acid exposure and symptom improvement. Conclusions: Twelve weeks after H. pylori eradication there was no consistent change in gastro-oesophageal acid reflux in patients with mild or moderate reflux oesophagitis.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 50 条
  • [31] Oesophageal motility and gastro-oesophageal reflux: Effect of variceal eradication by endoscopic sclerotherapy
    Ghoshal, UC
    Saraswat, VA
    Aggarwal, R
    Misra, A
    Dhiman, RK
    Naik, SR
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (10) : 1033 - 1038
  • [32] Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux:: Bristol helicobacter project
    Harvey, RF
    Lane, JA
    Murray, LJ
    Harvey, IM
    Donovan, JL
    Nair, P
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7453): : 1417 - 1419
  • [33] Helicobacter pylori and gastro-oesophageal reflux disease -: Information on underlying pathology is not given
    Cammarota, G
    Gasbarrini, GB
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7462): : 402 - 402
  • [34] Helicobacter pylori and gastro-oesophageal reflux disease -: clinical implications and management.
    O'Connor, HJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (02) : 117 - 127
  • [35] Symposium:: Helicobacter pylori and clinical risks -: focus on gastro-oesophageal reflux disease
    Malfertheiner, P
    O'Connor, HJ
    Genta, RM
    Unge, P
    Axon, ATR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 : 1 - 10
  • [36] Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease:: systematic review
    Raghunath, A
    Hungin, APS
    Wooff, D
    Childs, A
    BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7392): : 737 - 739
  • [37] Helicobacter pylori genotypes and expression of gastritis in erosive gastro-oesophageal reflux disease
    Leodolter, A
    Wolle, K
    Peitz, U
    Ebert, M
    Günther, T
    Kahl, S
    Malfertheiner, P
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) : 498 - 502
  • [38] Review article:: Helicobacter pylori and gastro-oesophageal reflux disease -: the European perspective
    McColl, KEL
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 36 - 39
  • [39] Review article:: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan
    Haruma, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 40 - 44
  • [40] Helicobacter pylori and gastro-oesophageal reflux disease -: Important data were not presented
    Beales, ILP
    BRITISH MEDICAL JOURNAL, 2004, 329 (7462): : 402 - 402